Fuente: WIPO "tomato" The present disclosure is directed to compositions comprising between 50% and 95% weight per weight (w/w) of acetic acid, between 0.1% and 5% (w/w) of butyric acid or a derivative thereof, and between 0.1% and 5% (w/w) of Quercetin or a derivative thereof. Further, methods of use such as for the treatment and prevention of a medical condition associated with cancer, inflammatory diseases or disorders, metabolic disorders, obesity, diabetes, high blood pressure, vascular diseases, viral infection, and any combination thereof, in a subject in need thereof are also provided.